Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma NfL levels, a disease progression biomarker, ...
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering
By adding Canada and the entire Latin America region, including Mexico, WODA completes its full global commercialization offering for rare and ...